Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye H Oo

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Drugs|October 1, 2004
Options for treatment of primary biliary cirrhosisYe H Oo, James Neuberger
Journal of Autoimmunity|September 12, 2009
The role of chemokines in the recruitment of lymphocytes to the liverYe H Oo, David H Adams
Hepatology International|July 21, 2018
Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cellsMuhammad Atif, Suz Warner, Ye H Oo
Mediators of Inflammation|August 31, 2012
Innate immune cells in liver inflammationEvaggelia Liaskou, Daisy V Wilson, Ye H Oo
ACG Case Reports Journal|July 12, 2024
Role of Sirolimus and Rituximab in the Treatment of Autoimmune HepatitisSpyridon Zouridis, Ye H Oo, Wing-Kin Syn
International Journal of Molecular Sciences|June 10, 2022
Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated CholangiopathiesNatalia M Krajewska, Rémi Fiancette, Ye H Oo
Digestive Diseases (Basel, Switzerland)|May 13, 2010
The role of chemokines in the recruitment of lymphocytes to the liverYe H Oo, Shishir Shetty, David H Adams
Hepatology International|September 10, 2010
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and managementYe H Oo, Stefan G Hubscher, David H Adams
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyNwe Ni Than, Hannah C Jeffery, Ye H Oo
Canadian Journal of Gastroenterology & Hepatology|December 20, 2016
Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy"Nwe Ni Than, Hannah C Jeffery, Ye H Oo
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Drugs|October 1, 2004
Options for treatment of primary biliary cirrhosisYe H Oo, James Neuberger
Journal of Autoimmunity|September 12, 2009
The role of chemokines in the recruitment of lymphocytes to the liverYe H Oo, David H Adams
Hepatology International|July 21, 2018
Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cellsMuhammad Atif, Suz Warner, Ye H Oo
Mediators of Inflammation|August 31, 2012
Innate immune cells in liver inflammationEvaggelia Liaskou, Daisy V Wilson, Ye H Oo
ACG Case Reports Journal|July 12, 2024
Role of Sirolimus and Rituximab in the Treatment of Autoimmune HepatitisSpyridon Zouridis, Ye H Oo, Wing-Kin Syn
International Journal of Molecular Sciences|June 10, 2022
Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated CholangiopathiesNatalia M Krajewska, Rémi Fiancette, Ye H Oo
Digestive Diseases (Basel, Switzerland)|May 13, 2010
The role of chemokines in the recruitment of lymphocytes to the liverYe H Oo, Shishir Shetty, David H Adams
Hepatology International|September 10, 2010
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and managementYe H Oo, Stefan G Hubscher, David H Adams
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyNwe Ni Than, Hannah C Jeffery, Ye H Oo
Canadian Journal of Gastroenterology & Hepatology|December 20, 2016
Corrigendum to "Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy"Nwe Ni Than, Hannah C Jeffery, Ye H Oo
Pageof 6